[1]
Shah Jihan et al. 2025. TOLERABILITY AND EFFICACY OF DAPAGLIFLOZIN IN NON – DIABETIC HEART FAILURE PATIENTS. Insights – Journal of Health and Rehabilitation. 3, 7 (Jul. 2025), 339–345. DOI:https://doi.org/10.71000/r97cc466.